Inhibition of Metabotropic Glutamate Receptor III Facilitates Sensitization to Alkylating Chemotherapeutics in Glioblastoma

Researchers mapped the manifold effects of glutamate signaling in glioblastoma (GBM) as the basis to further discover the regulatory role and interactions of specific receptors, within the GBM microenvironment.